Skip to main content
. 2022 Apr 29;9:863468. doi: 10.3389/fmed.2022.863468

Table 1.

Clinicopathologic features of the sample.

N %
BRCA
    BRCA1 16 30.8
    BRCA2 36 69.2
Gender
    Male 5 9.6
    Female 47 90.4
Hairs
    Blond 9 17.3
    Brown 35 67.3
    Black 8 15.4
Eyes
    Blue 15 28.8
    Brown 33 63.5
    Black 4 7.7
FP
    I
    II 16 30.8
    III 36 69.2
    IV
PCH
    Negative 29 55.8
    Positive* 26 44.2
CA
    Negative 37 71.2
    Positive** 7 13.5
    Unknown 6 11.5
CL
    None 24 46.2
    Positive 28 53.8
eCAs
    Negative 28 53.8
    Positive 24 46.2
TN
    >10 40 76.9
     ≤ 10 12 23.1
Patterns of nevi
    R 1.272 63
    MC 383 19.2
    MP 193 9.6
    G 115 5.7
    U 54 2.7

FP means Fitzpatrick's phototype;

*

Positive personal cancer history (PCH): 18 breast cancer, 4 ovarian cancer, 1 prostate cancer;

**

Positive cutaneous anamnesis (CA): actinic keratosis 1, basal cell carcinoma 1, atopic dermatitis 1, dermatofibroma 1, granuloma annulare 1, lipoma 1, prurigo 1, dysplastic nevus, unknown 6; cutaneous lesions identified during the visit CL: seborrheic keratosis 14, sebaceous hyperplasia 1, warts 2, dermatofibroma 2, skin tags 2, acne 2, microcystic lymphatic hyperplasia 1, lentigo 1, melanonychia 1, eruptive cherry angiomas 24, in situ melanoma 1, dysplastic nevus 1; TN means total number of nevi, with a mean number of nevi of 38 (standard deviation: 25.7). Regarding the patterns of nevi: uniform globular pattern (G), reticular pattern (R), mixed pattern composed of a central globular or structureless area surrounded by a network (MC), mixed pattern composed of a central network or structureless brown-gray area surrounded by a peripheral rim of small brown globules (MP), and unspecified pattern (U).

The analysis of the patterns of nevi was performed on a total of 2.020 melanocytic lesions that were evaluated in all 52 patients.